Robert Alver

Robert Alver, PhD, is a Senior Medical Science Liaison specializing in Hematology at AstraZeneca, where they have been contributing since 2018. With over 11 years of experience in academic research, Robert's work has focused on genomic stability mechanisms and has direct implications for drug development and translational oncology. They obtained a PhD in Biochemistry, Biophysics, and Molecular Biology from the University of Minnesota, where they also completed a BA in Biochemistry and German. Prior to AstraZeneca, Robert held positions as a Senior Research Fellow at Mayo Clinic and a Postdoctoral Research Assistant at the University of Dundee, where they conducted significant biomedical research and mentored students.